220 related articles for article (PubMed ID: 27802202)
1. Saturated fatty acids as possible important metabolites for epithelial ovarian cancer based on the free and esterified fatty acid profiles determined by GC-MS analysis.
Yin R; Yang T; Su H; Ying L; Liu L; Sun C
Cancer Biomark; 2016 Sep; 17(3):259-269. PubMed ID: 27802202
[TBL] [Abstract][Full Text] [Related]
2. Large-scale profiling of metabolic dysregulation in ovarian cancer.
Ke C; Hou Y; Zhang H; Fan L; Ge T; Guo B; Zhang F; Yang K; Wang J; Lou G; Li K
Int J Cancer; 2015 Feb; 136(3):516-26. PubMed ID: 24895217
[TBL] [Abstract][Full Text] [Related]
3. [Discrimination and clinical value of plasma metabolomic profiles in multidrug resistant epithelial ovarian cancer].
Wu WJ; Wang Q; Zhang W; Li L
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):896-902. PubMed ID: 29262505
[No Abstract] [Full Text] [Related]
4. Serum fatty acid profiles and potential biomarkers of ankylosing spondylitis determined by gas chromatography-mass spectrometry and multivariate statistical analysis.
Chen R; Han S; Dong D; Wang Y; Liu Q; Xie W; Li M; Yao M
Biomed Chromatogr; 2015 Apr; 29(4):604-11. PubMed ID: 25223299
[TBL] [Abstract][Full Text] [Related]
5. Identification of possible biomarkers for breast cancer from free fatty acid profiles determined by GC-MS and multivariate statistical analysis.
Lv W; Yang T
Clin Biochem; 2012 Jan; 45(1-2):127-33. PubMed ID: 22061338
[TBL] [Abstract][Full Text] [Related]
6. Distinct plasma lipids profiles of recurrent ovarian cancer by liquid chromatography-mass spectrometry.
Li J; Xie H; Li A; Cheng J; Yang K; Wang J; Wang W; Zhang F; Li Z; Dhillon HS; Openkova MS; Zhou X; Li K; Hou Y
Oncotarget; 2017 Jul; 8(29):46834-46845. PubMed ID: 27564116
[TBL] [Abstract][Full Text] [Related]
7. Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform.
Fan L; Zhang W; Yin M; Zhang T; Wu X; Zhang H; Sun M; Li Z; Hou Y; Zhou X; Lou G; Li K
Acta Oncol; 2012 Apr; 51(4):473-9. PubMed ID: 22283470
[TBL] [Abstract][Full Text] [Related]
8. Serum metabolite signatures of epithelial ovarian cancer based on targeted metabolomics.
Wang X; Zhao X; Zhao J; Yang T; Zhang F; Liu L
Clin Chim Acta; 2021 Jul; 518():59-69. PubMed ID: 33746017
[TBL] [Abstract][Full Text] [Related]
9. Predicting ovarian cancer recurrence by plasma metabolic profiles before and after surgery.
Zhang F; Zhang Y; Ke C; Li A; Wang W; Yang K; Liu H; Xie H; Deng K; Zhao W; Yang C; Lou G; Hou Y; Li K
Metabolomics; 2018 Apr; 14(5):65. PubMed ID: 30830339
[TBL] [Abstract][Full Text] [Related]
10. Prediction of advanced ovarian cancer recurrence by plasma metabolic profiling.
Zhang H; Ge T; Cui X; Hou Y; Ke C; Yang M; Yang K; Wang J; Guo B; Zhang F; Lou G; Li K
Mol Biosyst; 2015 Feb; 11(2):516-21. PubMed ID: 25424060
[TBL] [Abstract][Full Text] [Related]
11. Gas chromatography-mass spectrometry-based profiling of serum fatty acids in acetaminophen-induced liver injured rats.
Xiong YH; Xu Y; Yang L; Wang ZT
J Appl Toxicol; 2014 Feb; 34(2):149-57. PubMed ID: 23239188
[TBL] [Abstract][Full Text] [Related]
12. Potential metabolomic biomarkers for reliable diagnosis of Behcet's disease using gas chromatography/ time-of-flight-mass spectrometry.
Ahn JK; Kim J; Hwang J; Song J; Kim KH; Cha HS
Joint Bone Spine; 2018 May; 85(3):337-343. PubMed ID: 28549946
[TBL] [Abstract][Full Text] [Related]
13. BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism.
Wang ZQ; Faddaoui A; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Guillemette C; Gobeil S; Macdonald E; Vanderhyden B; Bachvarov D
Oncotarget; 2015 Oct; 6(31):31522-43. PubMed ID: 26372729
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
[TBL] [Abstract][Full Text] [Related]
15. Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer's disease.
Wang DC; Sun CH; Liu LY; Sun XH; Jin XW; Song WL; Liu XQ; Wan XL
Neurobiol Aging; 2012 Jun; 33(6):1057-66. PubMed ID: 20980076
[TBL] [Abstract][Full Text] [Related]
16. Wide-Targeted Metabolome Analysis Identifies Potential Biomarkers for Prognosis Prediction of Epithelial Ovarian Cancer.
Hishinuma E; Shimada M; Matsukawa N; Saigusa D; Li B; Kudo K; Tsuji K; Shigeta S; Tokunaga H; Kumada K; Komine K; Shirota H; Aoki Y; Motoike IN; Yasuda J; Kinoshita K; Yamamoto M; Koshiba S; Yaegashi N
Toxins (Basel); 2021 Jun; 13(7):. PubMed ID: 34209281
[TBL] [Abstract][Full Text] [Related]
17. Taurine, glutamic acid and ethylmalonic acid as important metabolites for detecting human breast cancer based on the targeted metabolomics.
Wang X; Zhao X; Chou J; Yu J; Yang T; Liu L; Zhang F
Cancer Biomark; 2018; 23(2):255-268. PubMed ID: 30103303
[TBL] [Abstract][Full Text] [Related]
18. Metabolic profiling and novel plasma biomarkers for predicting survival in epithelial ovarian cancer.
Xie H; Hou Y; Cheng J; Openkova MS; Xia B; Wang W; Li A; Yang K; Li J; Xu H; Yang C; Ma L; Li Z; Fan X; Li K; Lou G
Oncotarget; 2017 May; 8(19):32134-32146. PubMed ID: 28389631
[TBL] [Abstract][Full Text] [Related]
19. Serum 27-nor-5β-cholestane-3,7,12,24,25 pentol glucuronide discovered by metabolomics as potential diagnostic biomarker for epithelium ovarian cancer.
Chen J; Zhang X; Cao R; Lu X; Zhao S; Fekete A; Huang Q; Schmitt-Kopplin P; Wang Y; Xu Z; Wan X; Wu X; Zhao N; Xu C; Xu G
J Proteome Res; 2011 May; 10(5):2625-32. PubMed ID: 21456628
[TBL] [Abstract][Full Text] [Related]
20. Targeting of free fatty acid receptor 1 in EOC: A novel strategy to restrict the adipocyte-EOC dependence.
Munkarah A; Mert I; Chhina J; Hamid S; Poisson L; Hensley-Alford S; Giri S; Rattan R
Gynecol Oncol; 2016 Apr; 141(1):72-9. PubMed ID: 27016232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
